Fri, 1 January 2016
Xalkori (critzotinib) was the first approved treatment for ALK+ and ROS1 lung cancer. Since then, other drugs have been approved or are currently undergoing scientific review. In this video, Dr. Owonikoko outlines these options for patients.
Direct download: GRACEcast-437_AR_2015_Owonikoko_New_Ideas_Treatment_Options_ALK_ROS1.mp4
Category:Lung-Cancer-Video -- posted at: 3:07pm PDT